{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:26:13Z","timestamp":1790673973402,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T00:00:00Z","timestamp":1458086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1038\/ejhg.2016.13","type":"journal-article","created":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T11:22:17Z","timestamp":1458127337000},"page":"1310-1315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["CAG repeat size in Huntingtin alleles is associated with cancer prognosis"],"prefix":"10.1038","volume":"24","author":[{"name":"for GEMO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane Sonia","family":"Thion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"T\u00e9zenas du Montcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Golmard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Vacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Barjhoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Sornin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Cazeneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Bi\u00e8che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Sinilnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Stoppa-Lyonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Durr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,16]]},"reference":[{"key":"BFejhg201613_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"Group THsDCR: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","year":"1993","unstructured":"Group THsDCR: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes: The Huntington's Disease Collaborative Research Group. Cell 1993; 72: 971\u2013983.","journal-title":"Cell"},{"key":"BFejhg201613_CR2","first-page":"16","volume":"59","author":"DC Rubinsztein","year":"1996","unstructured":"Rubinsztein DC, Leggo J, Coles R, et al: Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 1996; 59: 16\u201322.","journal-title":"Am J Hum Genet"},{"key":"BFejhg201613_CR3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","volume":"4","author":"SE Andrew","year":"1993","unstructured":"Andrew SE, Goldberg YP, Kremer B, et al: The relationship between trinucleotide (Cag) repeat length and clinical-features of Huntingtons-disease. Nat Genet 1993; 4: 398\u2013403.","journal-title":"Nat Genet"},{"key":"BFejhg201613_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng0893-393","volume":"4","author":"RG Snell","year":"1993","unstructured":"Snell RG, MacMillan JC, Cheadle JP, et al: Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet 1993; 4: 393\u2013397.","journal-title":"Nat Genet"},{"key":"BFejhg201613_CR5","doi-asserted-by":"crossref","unstructured":"Semaka A, Hayden M : Evidence-based genetic counselling implications for Huntington disease intermediate allele predictive test results. Clin Genet 2013.","DOI":"10.1111\/cge.12324"},{"key":"BFejhg201613_CR6","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1212\/WNL.0b013e318294b304","volume":"80","author":"A Killoran","year":"2013","unstructured":"Killoran A, Biglan KM, Jankovic J, et al: Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS. Neurology 2013; 80: 2022\u20132027.","journal-title":"Neurology"},{"key":"BFejhg201613_CR7","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/S1470-2045(12)70132-8","volume":"13","author":"J Ji","year":"2012","unstructured":"Ji J, Sundquist K, Sundquist J : Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden. Lancet Oncol 2012; 13: 642\u2013648.","journal-title":"Lancet Oncol"},{"key":"BFejhg201613_CR8","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1342::AID-CNCR33>3.0.CO;2-3","volume":"86","author":"SA Sorensen","year":"1999","unstructured":"Sorensen SA, Fenger K, Olsen JH : Significantly lower incidence of cancer among patients with Huntington disease: an apoptotic effect of an expanded polyglutamine tract? Cancer 1999; 86: 1342\u20131346.","journal-title":"Cancer"},{"key":"BFejhg201613_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/emmm.201201546","volume":"5","author":"C Moreira Sousa","year":"2013","unstructured":"Moreira Sousa C, McGuire JR, Thion MS, et al: The Huntington disease protein accelerates breast tumour development and metastasis through ErbB2\/HER2 signalling. EMBO Mol Med 2013; 5: 309\u2013325.","journal-title":"EMBO Mol Med"},{"key":"BFejhg201613_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/oxfordjournals.epirev.a036115","volume":"15","author":"JL Kelsey","year":"1993","unstructured":"Kelsey JL, Gammon MD, John EM : Reproductive factors and breast cancer. Epidemiol Rev 1993; 15: 36\u201347.","journal-title":"Epidemiol Rev"},{"key":"BFejhg201613_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrc1431","volume":"4","author":"SA Narod","year":"2004","unstructured":"Narod SA, Foulkes WD : BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 2004; 4: 665\u2013676.","journal-title":"Nat Rev Cancer"},{"key":"BFejhg201613_CR12","doi-asserted-by":"publisher","first-page":"384e371","DOI":"10.1038\/ng.2566","volume":"45","author":"SE Bojesen","year":"2013","unstructured":"Bojesen SE, Pooley KA, Johnatty SE, et al: Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013; 45: 384e371\u2013372.","journal-title":"Nat Genet"},{"key":"BFejhg201613_CR13","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/ng.669","volume":"42","author":"AC Antoniou","year":"2010","unstructured":"Antoniou AC, Wang X, Fredericksen ZS, et al: A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 2010; 42: 885\u2013892.","journal-title":"Nat Genet"},{"key":"BFejhg201613_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/bcr1670","volume":"9","author":"G Chenevix-Trench","year":"2007","unstructured":"Chenevix-Trench G, Milne RL, Antoniou AC, et al: An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res 2007; 9: 104.","journal-title":"Breast Cancer Res"},{"key":"BFejhg201613_CR15","doi-asserted-by":"publisher","first-page":"8109","DOI":"10.1038\/sj.onc.1204917","volume":"20","author":"I Bieche","year":"2001","unstructured":"Bieche I, Parfait B, Laurendeau I, et al: Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer. Oncogene 2001; 20: 8109\u20138115.","journal-title":"Oncogene"},{"key":"BFejhg201613_CR16","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1002\/ijc.27600","volume":"131","author":"KD Awadelkarim","year":"2012","unstructured":"Awadelkarim KD, Callens C, Rosse C, et al: Quantification of PKC family genes in sporadic breast cancer by qRT-PCR: evidence that PKCiota\/lambda overexpression is an independent prognostic factor. Int J Cancer 2012; 131: 2852\u20132862.","journal-title":"Int J Cancer"},{"key":"BFejhg201613_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/gepi.21620","volume":"36","author":"DR Barnes","year":"2012","unstructured":"Barnes DR, Lee A, Investigators E et al: Evaluation of association methods for analysing modifiers of disease risk in carriers of high-risk mutations. Genet Epidemiol 2012; 36: 274\u2013291.","journal-title":"Genet Epidemiol"},{"key":"BFejhg201613_CR18","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1086\/522611","volume":"81","author":"AC Antoniou","year":"2007","unstructured":"Antoniou AC, Sinilnikova OM, Simard J, et al: RAD51 135G\u2014&gt;C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 2007; 81: 1186\u20131200.","journal-title":"Am J Hum Genet"},{"key":"BFejhg201613_CR19","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1212\/WNL.0b013e318249f683","volume":"78","author":"JM Lee","year":"2012","unstructured":"Lee JM, Ramos EM, Lee JH, et al: CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology 2012; 78: 690\u2013695.","journal-title":"Neurology"},{"key":"BFejhg201613_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/ejhg.2008.142","volume":"17","author":"RJ Tassicker","year":"2009","unstructured":"Tassicker RJ, Teltscher B, Trembath MK, et al: Problems assessing uptake of Huntington disease predictive testing and a proposed solution. Eur J Hum Genet 2009; 17: 66\u201370.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg201613_CR21","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1136\/jnnp-2012-304636","volume":"84","author":"SJ Evans","year":"2013","unstructured":"Evans SJ, Douglas I, Rawlins MD, et al: Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records. J Neurol Neurosurg Psychiatry 2013; 84: 1156\u20131160.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFejhg201613_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1399-0004.2010.01538.x","volume":"80","author":"PJ Morrison","year":"2011","unstructured":"Morrison PJ, Harding-Lester S, Bradley A : Uptake of Huntington disease predictive testing in a complete population. Clin Genet 2011; 80: 281\u2013286.","journal-title":"Clin Genet"},{"key":"BFejhg201613_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/mds.25717","volume":"29","author":"ER Fisher","year":"2013","unstructured":"Fisher ER, Hayden MR : Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk. Mov Disord 2013; 29: 105\u2013114.","journal-title":"Mov Disord"},{"key":"BFejhg201613_CR24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3233\/JHD-130082","volume":"2","author":"C Moreira Sousa","year":"2013","unstructured":"Moreira Sousa C, Humbert S : Huntingtin: here, there, everywhere!. J Huntingtons Dis 2013; 2: 395\u2013403.","journal-title":"J Huntingtons Dis"},{"key":"BFejhg201613_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.stemcr.2014.02.011","volume":"2","author":"S Elias","year":"2014","unstructured":"Elias S, Thion MS, Yu H, et al: Huntingtin regulates mammary stem cell division and differentiation. Stem Cell Rep 2014; 2: 491\u2013506.","journal-title":"Stem Cell Rep"},{"key":"BFejhg201613_CR26","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.molcel.2004.09.016","volume":"15","author":"H Goehler","year":"2004","unstructured":"Goehler H, Lalowski M, Stelzl U, et al: A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. Mol Cell 2004; 15: 853\u2013865.","journal-title":"Mol Cell"},{"key":"BFejhg201613_CR27","doi-asserted-by":"publisher","first-page":"djv208","DOI":"10.1093\/jnci\/djv208","volume":"107","author":"MS Thion","year":"2015","unstructured":"Thion MS, McGuire JR, Sousa CM, et al: Unraveling the role of Huntingtin in breast cancer metastasis. J Natl Cancer Inst 2015; 107: djv208.","journal-title":"J Natl Cancer Inst"},{"key":"BFejhg201613_CR28","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/jmedgenet-2013-101796","volume":"50","author":"A Semaka","year":"2013","unstructured":"Semaka A, Kay C, Doty C, et al: CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease. J Med Genet 2013; 50: 696\u2013703.","journal-title":"J Med Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg201613.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201613","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201613.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:16:20Z","timestamp":1684430180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg201613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,16]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["BFejhg201613"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2016.13","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,16]]},"assertion":[{"value":"4 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}